Show simple item record

dc.contributor.authorNordsmark, Marianne
dc.contributor.authorLoncaster, Juliette A
dc.contributor.authorAquino-Parsons, Christina
dc.contributor.authorChou, Shu-Chuan
dc.contributor.authorLadekarl, Morten
dc.contributor.authorHavsteen, Hanne
dc.contributor.authorLindegaard, Jacob C
dc.contributor.authorDavidson, Susan E
dc.contributor.authorVaria, Mahesh
dc.contributor.authorWest, Catharine M L
dc.contributor.authorHunter, Robin D
dc.contributor.authorOvergaard, Jens
dc.contributor.authorRaleigh, James A
dc.date.accessioned2009-08-21T14:35:06Z
dc.date.available2009-08-21T14:35:06Z
dc.date.issued2003-04
dc.identifier.citationMeasurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas. 2003, 67 (1):35-44 Radiother Oncolen
dc.identifier.issn0167-8140
dc.identifier.pmid12758238
dc.identifier.urihttp://hdl.handle.net/10541/78229
dc.description.abstractBACKGROUND AND PURPOSE: The measurement of tumour oxygenation using Eppendorf oxygen-sensitive needle electrodes can provide prognostic information but the method is limited to accessible tumours that are suitable for electrode insertion. In this paper the aim was to study the relationship between such physiological measurements of tumour hypoxia and the labelling of tumours with the hypoxia-specific marker pimonidazole. MATERIALS AND METHODS: Assessment of tumour oxygen partial pressure (pO(2)) using an Eppendorf pO(2) histograph and immunohistochemical pimonidazole labelling was carried out in 86 patients with primary cervix carcinomas. Pimonidazole was given as a single injection (0.5 g/m(2) i.v.) and 10-24 h later pO(2) measurements were made and biopsies taken. Tumour oxygenation status was evaluated as the median tumour pO(2) and the fraction of pO(2) values
dc.language.isoenen
dc.subjectUterine Cervical Canceren
dc.subject.meshAdolescent
dc.subject.meshAdult
dc.subject.meshAnalysis of Variance
dc.subject.meshCarcinoma
dc.subject.meshCell Hypoxia
dc.subject.meshComputer Graphics
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMicroelectrodes
dc.subject.meshNitroimidazoles
dc.subject.meshOxygen
dc.subject.meshPolarography
dc.subject.meshRadiation-Sensitizing Agents
dc.subject.meshRetrospective Studies
dc.subject.meshStatistics, Nonparametric
dc.subject.meshUterine Cervical Neoplasms
dc.titleMeasurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas.en
dc.typeArticleen
dc.contributor.departmentDepartment of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.en
dc.identifier.journalRadiotherapy and Oncologyen
html.description.abstractBACKGROUND AND PURPOSE: The measurement of tumour oxygenation using Eppendorf oxygen-sensitive needle electrodes can provide prognostic information but the method is limited to accessible tumours that are suitable for electrode insertion. In this paper the aim was to study the relationship between such physiological measurements of tumour hypoxia and the labelling of tumours with the hypoxia-specific marker pimonidazole. MATERIALS AND METHODS: Assessment of tumour oxygen partial pressure (pO(2)) using an Eppendorf pO(2) histograph and immunohistochemical pimonidazole labelling was carried out in 86 patients with primary cervix carcinomas. Pimonidazole was given as a single injection (0.5 g/m(2) i.v.) and 10-24 h later pO(2) measurements were made and biopsies taken. Tumour oxygenation status was evaluated as the median tumour pO(2) and the fraction of pO(2) values </=10 mmHg (HP(10)), </=5 mmHg (HP(5)) and </=2.5 mmHg (HP(2.5)). Hypoxia was detected by immunohistochemistry using monoclonal antibodies directed against reductively activated pimonidazole. Pimonidazole binding was scored using a light microscope. Each tumour was evaluated by the relative area pimonidazole at highest score and the accumulated area of pimonidazole labelling from score 1 to 4. Necrosis was measured in HE stained sections. RESULTS AND CONCLUSIONS: The degree of hypoxia assessed by either pimonidazole binding or invasive electrode measurements varied significantly between tumours. There was a trend that the most hypoxic tumours measured by oxygen electrodes had the highest score of necrosis, and no or little pimonidazole binding. However, this observation was not consistent and there was no correlation between pimonidazole staining expressed in this way and oxygen electrode measurements of hypoxia.


This item appears in the following Collection(s)

Show simple item record